AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 OCT 7 - (NewsRx.com & NewsRx.net) -- Alliant Pharmaceuticals, Inc., announced U.S. Food and Drug Administration (FDA) approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD.
The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.
Lyndon Waugh, MD, clinical assistant professor of child and adolescent psychiatry at Emory University, said, "The release of this effective, well established medication for ADHD in liquid and chewable tablet form will allow physicians another alternative to carefully fine-tune a dosing strategy for each individual patient.
"And, it will help diminish family conflict and the child's anxiety when they have difficulty swallowing capsules or tablets."
Currently 26% of the total population has difficulty in swallowing tablets and capsules. This ...
Source: HighBeam Research, FDA approves Methylin Chewable Tablets, Methylin Oral Solution for...